Prostate Enlargement (BPH) Treatments: Options & Solutions

Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate that obstructs urine flow. Treatment is tailored to symptom severity, prostate size, and patient preference.

1. Medications (First-Line)

  • Alpha-blockers (tamsulosin, alfuzosin): Relax prostate/bladder neck muscle—rapid symptom relief (days). Side effects: dizziness, retrograde ejaculation.
  • 5-Alpha-Reductase Inhibitors (finasteride, dutasteride): Shrink prostate over 6–12 months by blocking DHT. Best for larger prostates (>30–40g). Side effects: sexual dysfunction.
  • Combination therapy: Often more effective than either alone.
  • PDE5 inhibitors (tadalafil 5 mg daily): Approved for BPH + ED.

2. Minimally Invasive Procedures (Office/Outpatient)

  • Prostatic Urethral Lift (UroLift): Implants hold lobes apart. No tissue removal; preserves ejaculation; quick recovery.
  • Water Vapor Therapy (Rezūm): Steam ablates tissue. Local anesthesia; 1–2 week recovery.
  • Microwave Thermotherapy (TUMT): Heat via urethral antenna. Older, less used now.
  • Temporary Implant (iTind): Expandable device left 5–7 days to reshape urethra.

3. Surgical Options (Operating Room)

  • TURP (Transurethral Resection of Prostate): Gold standard for >30–80g prostates. Removes tissue via resectoscope. ~1–2 night stay. Risk: TUR syndrome (rare), retrograde ejaculation (75%), stricture.
  • HoLEP (Holmium Laser Enucleation): Enucleates adenoma; works for any size; less bleeding; shorter catheter time; steep learning curve.
  • GreenLight Laser (PVP): Vaporizes tissue; good for anticoagulated patients.
  • Simple Prostatectomy (open/robotic): For very large prostates (>80–100g). Higher morbidity.

Decision-Making

Shared decision-making with a urologist balances symptom bother (IPSS score), prostate size (ultrasound/MRI), comorbidities, sexual function priorities, and anesthesia tolerance.

Medical Conditions - Related Articles